E-LIB Suche - Ergebnisse für: Orsolya Somogyi

1

New Data on the Features of Skin Barrier in Hidradenitis Su..:

Orsolya Somogyi ; Zsolt Dajnoki ; Lilla Szabó...
Immunology and Immunotherapy. , 2023

Link: https://doi.org/10.3390/..

2

Antimicrobial Peptide Loss, Except for LL-37, is not Charac..:

Lilla Szabó ; Anikó Kapitány ; Orsolya Somogyi...
https://medicaljournalssweden.se/actadv/article/view/9413. , 2023

Link: https://doi.org/10.2340/..

3

New Data on the Features of Skin Barrier in Hidradenitis Su..:

Orsolya Somogyi ; Zsolt Dajnoki ; Lilla Szabó...
https://www.mdpi.com/2227-9059/11/1/127. , 2023

Link: https://doi.org/10.3390/..

4

Implementation of a personal health planning program and he..:

Dénes Kleiner ; Orsolya Somogyi ; Fruzsina Hedvig Petlickij...
http://www.sciencedirect.com/science/article/pii/S2405844022011884. , 2022

Link: https://doi.org/10.1016/..

5

Regional Differences in the Permeability Barrier of the Ski..:

Anikó Kapitány ; Barbara Medgyesi ; Adrienn Jenei...
Biochemistry. , 2021

Link: https://doi.org/10.3390/..

6

Regional Differences in the Permeability Barrier of the Ski..:

Anikó Kapitány ; Barbara Medgyesi ; Adrienn Jenei...
https://www.mdpi.com/1422-0067/22/19/10428. , 2021

Link: https://doi.org/10.3390/..

7

Analysis of interaction risks of patients with polypharmacy..:

András Szilvay ; Orsolya Somogyi ; Annamária Dobszay...
https://doi.org/10.1371/journal.pone.0253645. , 2021

Link: https://doi.org/10.1371/..

8

Establishment of a communication environment supporting low..:

Attiláné Meskó ; Balázs Hankó ; András Szilvay...
https://bmjopen.bmj.com/content/10/12/e039603.full. , 2020

Link: https://doi.org/10.1136/..

9

Qualitative and quantitative research of medication review ..:

András Szilvay ; Orsolya Somogyi ; Attiláné Meskó..
http://link.springer.com/article/10.1186/s12913-019-4114-1. , 2019

Link: https://doi.org/10.1186/..

10

Frequency of interaction risks grouped by the competent hea..:

András Szilvay (11008914) ; Orsolya Somogyi (11008917) ; Annamária Dobszay (11008920)...
https://figshare.com/articles/figure/Frequency_of_interaction_risks_grouped_by_the_competent_healthcare_professional_providing_the_necessary_intervention_and_a_complete_solution_and_by_the_prescribing_and_dispensing_category_of_the_drugs_involved_/14824341. , 2021

Link: https://doi.org/10.1371/..

11

Distribution of interactions by clinical risk caused by act..:

András Szilvay (11008914) ; Orsolya Somogyi (11008917) ; Annamária Dobszay (11008920)...
https://figshare.com/articles/figure/Distribution_of_interactions_by_clinical_risk_caused_by_active_substances_causing_the_most_Grade_A_B_or_Grade_D_X_interactions_/14824347. , 2021

Link: https://doi.org/10.1371/..

12

Drug-Related Problem (DRP) classification and their underly..:

András Szilvay (11008914) ; Orsolya Somogyi (11008917) ; Annamária Dobszay (11008920)...
https://figshare.com/articles/dataset/Drug-Related_Problem_DRP_classification_and_their_underlying_cause_41_/14824356. , 2021

Link: https://doi.org/10.1371/..

13

Definitions of pharmacist interventions to solve drug-relat..:

András Szilvay (11008914) ; Orsolya Somogyi (11008917) ; Annamária Dobszay (11008920)...
https://figshare.com/articles/dataset/Definitions_of_pharmacist_interventions_to_solve_drug-related_problems_/14824365. , 2021

Link: https://doi.org/10.1371/..

14

The incidence of pharmacist interventions to solve interact..:

András Szilvay (11008914) ; Orsolya Somogyi (11008917) ; Annamária Dobszay (11008920)...
https://figshare.com/articles/figure/The_incidence_of_pharmacist_interventions_to_solve_interaction_risks_in_order_of_frequency_/14824350. , 2021

Link: https://doi.org/10.1371/..

15

The distribution and order of occurrence of the underlying ..:

András Szilvay (11008914) ; Orsolya Somogyi (11008917) ; Annamária Dobszay (11008920)...
https://figshare.com/articles/figure/The_distribution_and_order_of_occurrence_of_the_underlying_causes_of_drug-related_problems_/14824338. , 2021

Link: https://doi.org/10.1371/..